INTRODUCTION
Castleman's disease (CD) is a rare atypical lymphoproliferative disorder whose morphology, soon after the original presentation of Castleman et al, has been definitely subdivided into hyaline vascular (HV), plasma cell (PC) and mixed variants. The former occurs much more frequently than the latter and is usually localized to the mediastinum or pulmonary hilum. The latter involves lymph nodes separately or in aggregations and often displays multicentricity with systemic symptoms including autoimmune phenomena and aggressive course. 
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REPORT
A 30 year old male wood worker who was a chronic alcoholic and tobacco chewer came with complaints of right sided chest pain and an intermittent cough for 1 month. Physical examination of the patient revealed good general condition. The vitals were within the normal limits. The remainder of systemic examination was normal.
The laboratory findings were significant for following values: WBC count 8400/cumm (neutrophils-71, lymphocytes-25, eosinophils-01 and monocytes-03), haemoglobin-13.0gm%. The remaining biochemical evaluation values and the coagulation profile were within normal limits. Human immunodeficiency virus and hepatitis virus (B and C) titers were not indicative of any recent or remote infections.
Bronchoscopy revealed normal segmental bronchi and Ultrasonogram (USG) abdomen revealed a normal scan. The chest radiograph was normal. The computerized tomography (CT) of chest revealed well-defined, smoothly marginated, solid mass (4.4x4x3.6cm) in the right hilum which showed strong contrast enhancement with small nonenhancing areas (fig 1) .
Grossly, the mass was 4x3.5x3cm, single; cut surface was homogenous and grey-white coloured. Histopathologic examination revealed a mass of lymphoid tissue having germinal center follicles with prominent mantle zones comprised of small, mature lymphocytes arranged in concentric layers with prominent hyalinized vessels. Prominent endothelial cells were seen in the vessels extending into the adjacent interfollicular area ( fig. 2  A and B) . Morphologic features showed no abnormal haematolymphoid population and was labelled as hyaline vascular type of Castlemans disease. The post operative period was uneventful.
DISCUSSION
CD is a benign lymphoproliferative disorder characterized by enlarged hyperplastic lymph nodes. In 1956 Benjamin Castleman and his associates described this disease. 1 Since then it is also recognized as angiofollicular lymphoid hyperplasia, giant lymph node hyperplasia, lymphoid hyperplasia, benign lymphoma, and follicular lympho- reticuloma. 2 It can present as a localized mass or as a multicentric disorder. Its presents as a pulmonary hilar mass loosely adherent to the pulmonary artery has been reported in the literature. 3 Histologically, three variants are recognized. They are HV, PC, and intermediate type. 4 HV type is the most common presentation. This type is usually localized to the mediastinum or pulmonary hilum. 5 This is similar to our patient who presented with mass in the pulmonary hilum. Lymph nodes from various animal models and patients with CD implicate IL-6 as a causative agent for the commonly observed systemic manifestations. [5] [6] [7] [8] [9] [10] Localized disease usually has a benign course and can present as an asymptomatic mass or with compression effect in respective area and also as pyrexia of unknown origin, weight loss or anemia. 5 Multicentric disease is usually a systemic illness involving the retroperitoneum, neck, parotids and muscles. It can also present as a disseminated lymphadenopathy. It is aggressive and usually the fatal course is associated with infectious complications and risks for malignant tumors such as lymphoma or Kaposi sarcoma.
The classical histopathological picture consists of thickened hyalinized capillaries within the follicle centres. There is perifollicular vascular proliferation with concentric layering of cells within germinal centres. There may be more than one germinal center within a single follicle.
Surgical excision is curative for the localized disease. Multicentric disease is usually associated with systemic manifestations and its prognosis is guarded. Its management includes a multimodality approach comprising of surgery, combination chemotherapy, steroids and radiation. Lately, anti-IL-6 receptor antibody therapy has been tried. 11 Adjunctive radiotherapy could be an option in patients who are at high risk of recurrence or unsuitable for surgery.
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CONCLUSION
CD is a challenging histopathological case to evaluate because of its rare incidence and nonspecific clinical features and results of radiological examination, and definite diagnosis depends on true histology.
